The Christie NHS Foundation Trust: Lung Neoplasms trials

The registry lists 12 Lung Neoplasms studies with The Christie NHS Foundation Trust as lead sponsor. 1 are open to participants now and 0 have results posted.

Phase 1 1Phase 2 1Phase 3 3No phase 8(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• A Feasibility Study of MRI Guided Stereotactic Ablative Radiotherapy (MIDSECTION)RecruitingNCT05903430
• Pragmatic Analysis of Complex Radiotherapy Cases In Cancer of the LungActive, not recruitingNCT07202260
• Impact on Quality of Life From Multi-modality Lung CancerStatus unknownNCT04540757
• Impact of COVID-19 on Lung Cancer PatientsCompletedNCT04538456
• A Translational Study Investigating PD-L1 Expression After Radiotherapy for Non-small Cell Lung CancerCompletedNCT03258788
• Respiratory Distress Symptom Intervention (RDSI) TrialCompletedNCT03223805Not applicable
• Magnetic Resonance Imaging (MRI) for the Delineation of Organs At Risk (OAR) and Target Volumes in Lung Cancer PatientsCompletedNCT03048760Not applicable
• MEK Inhibitor and Thoracic Radiotherapy TrialCompletedNCT01146756Phase 1
• Concurrent Once Daily Versus Twice Daily Radiotherapy for Limited Stage Small Cell Lung CancerCompletedNCT00433563Not applicable
• Hospitalization Rates of Patients With Non-Small Cell Lung Cancer Treated With Gemcitabine and Either Cisplatin or CarboplatinStatus unknownNCT00055965Phase 3
• Gemcitabine Plus Supportive Care in Treating Patients With Locally Advanced or Metastatic Non-Small Cell Lung CancerStatus unknownNCT00022009Phase 2/3
• Paclitaxel and Carboplatin Chemotherapy Compared With Standard Chemotherapy in Treating Patients With Stage III or Stage IV Non-small Cell Lung Cancer That Cannot Be Removed During SurgeryStatus unknownNCT00004887Phase 3